Head to Head Survey: I-Mab (NASDAQ:IMAB) and Iterum Therapeutics (NASDAQ:ITRM)
I-Mab (NASDAQ:IMAB – Get Rating) and Iterum Therapeutics (NASDAQ:ITRM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations. Risk & Volatility I-Mab has a beta of 0.94, indicating […]
Source: etfdailynews.com